Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
11248 Results
7061
Overdose Experiences among People Who Inject Drugs in West Virginia: Personal Loss, Psychological Distress, Naloxone, and Fentanyl
Type: Journal Article
Authors: K. E. Schneider, S. T. Allen, A. K. Winiker, R. H. White, A. O'Rourke, S. G. Sherman, S. M. Grieb
Year: 2023
Abstract:

Background: As overdose remains a major public health concern in the United States, it is important to understand the experiences people who inject drugs (PWID) have with overdose. Past experiences during such emergencies are an important determinant of future behavior, including help seeking, which can be lifesaving. Methods: We explored experiences with overdose, using data from 21 in-depth interviews collected from PWID in a rural county in West Virginia (Cabell County). We used an iterative, modified constant comparison approach to synthesize resulting interview data. Results: Participants reported pervasive experiences with overdose, including through their own personal overdose experiences, witnessing others overdose, and losing loved ones to overdose fatalities. Experiencing emotional distress when witnessing an overdose was common among our participants. Many participants reported regularly carrying naloxone and using it to reverse overdoses. Multiple participants described believing the myth that people grow immune to naloxone over time. Concerns about the presence of fentanyl in drugs were also common, with many participants attributing their own and others' overdoses to fentanyl. Conclusions: Our findings have important implications for naloxone access and education, as well as policies and practices to encourage help seeking during overdose events among rural PWID. Participant concerns about fentanyl in the drug supply highlight the need for access to drug checking technologies.

Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
7062
Overdose Prevention and Response Toolkit
Type: Web Resource
Authors: Substance Abuse and Mental Health Services Administration
Year: 2024
Publication Place: Rockville, MD
Topic(s):
Opioids & Substance Use See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7063
Overdose prevention in injecting opioid users: the role of substance abuse treatment and training programs
Type: Journal Article
Authors: A. Sarasa-Renedo, A. Espelt, C. Folch, C. Vecino, X. Majo, Y. Castellano, J. Casabona, M. T. Brugal, Redan Study Group
Year: 2014
Publication Place: Spain
Topic(s):
Opioids & Substance Use See topic collection
7064
Overdose prevention training with naloxone distribution in a prison in Oslo, Norway: A preliminary study
Type: Journal Article
Authors: Aase Grønlien Petterson, Desiree Madah-Amiri
Year: 2017
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7065
Overdose response training and naloxone distribution among rural first responders
Type: Journal Article
Authors: Claire A. Wood, Alex Duello, Phil Horn, Rachel Winograd, Lillie Jackson, Sandra Mayen, Karen Wallace
Year: 2021
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
7066
Overdose Risk in Young Children of Women Prescribed Opioids
Type: Journal Article
Authors: Yaron Finkelstein, Erin M. Macdonald, Alejandro Gonzalez, Marco L. A. Sivilotti, Muhammad M. Mamdani, David N. Juurlink, Canadian Drug Safety And Effectiveness Research Network
Year: 2017
Publication Place: United States
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7067
Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses
Type: Journal Article
Authors: J. Strang, V. Manning, S. Mayet, D. Best, E. Titherington, L. Santana, E. Offor, C. Semmler
Year: 2008
Publication Place: England
Abstract: AIM: To examine the impact of training in overdose management and naloxone provision on the knowledge and confidence of current opiate users; and to record subsequent management of overdoses that occur during a 3-month follow-up period. DESIGN: Repeated-measures design to examine changes in knowledge and confidence immediately after overdose management training; retention of knowledge and confidence at 3 months; and prospective cohort study design to document actual interventions applied at post-training overdose situations. METHOD: A total of 239 opiate users in treatment completed a pre-training questionnaire on overdose management and naloxone administration and were re-assessed immediately post-training, at which point they were provided with the take-home emergency supply of naloxone. Three months later they were re-interviewed. RESULTS: Significant improvements were seen in knowledge of risks of overdose, characteristics of overdose and appropriate actions to be taken; and in confidence in the administration of naloxone. A 78% follow-up rate was achieved (186 of 239) among whom knowledge of both the risks and physical/behavioural characteristics of overdose and also of recommended management actions was well retained. Eighteen overdoses (either experienced or witnessed) had occurred during the 3 months between the training and the follow-up. Naloxone was used on 12 occasions (a trained client's own supply on 10 occasions). One death occurred in one of the six overdoses where naloxone was not used. Where naloxone was used, all 12 resulted in successful reversal. CONCLUSIONS: With overdose management training, opiate users can be trained to execute appropriate actions to assist the successful reversal of potentially fatal overdose. Wider provision may reduce drug-related deaths further. Future studies should examine whether public policy of wider overdose management training and naloxone provision could reduce the extent of opiate overdose fatalities, particularly at times of recognized increased risk.
Topic(s):
Opioids & Substance Use See topic collection
7069
Overview of integrated primary care
Type: Book Chapter
Authors: Anne C. Dobmeyer
Year: 2018
Publication Place: Washington, DC
Topic(s):
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Reference Links:       
7070
Overview of Medications Used in the Treatment of Alcohol Use Disorder and Frequently Asked Questions
Type: Government Report
Authors: Agency for Healthcare Research and Quality
Year: 2022
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7071
Overview of Opioid Treatment Program Regulations by State
Type: Government Report
Authors: Pew Research Center
Year: 2022
Publication Place: Washington, D.C.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Policy See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7072
Overview of the Impacts of Long COVID on Behavioral Health
Type: Web Resource
Authors: Substance Abuse and Mental Health Services Administration
Year: 2023
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7073
Overweight prevention in pediatric primary care: a needs assessment of an urban racial/ethnic minority population
Type: Journal Article
Authors: P. A. Asante, J. Cox, K. Sonneville, R. C. Samuels, E. M. Taveras
Year: 2009
Publication Place: United States
Abstract: The authors studied the prevalence of overweight-related behaviors in an urban clinic population, parents' perceived willingness to change, and identified potential gaps in nutrition and physical activity promotion. A total of 324 parents of children aged 3 to 13 years were surveyed. Clinical heights and weights were used to calculate body mass index (BMI). Of the 324 children in the study, 55% were black and 28% were Hispanic. Approximately 151 (47%) children had a BMI > or =85th percentile, and overweight-related behaviors, such as TV viewing, were highly prevalent. Overall, parents reported a need for counseling to help their children eat healthier and be more active and seemed willing to make behavior changes in these areas. However, their willingness to change appeared lowest in areas that may improve their child's weight status such as decreasing sedentary time and portion sizes. Overweight prevention efforts in primary care should include strategies to help clinicians negotiate behavior change with families.
Topic(s):
HIT & Telehealth See topic collection
7074
Oxidative Metabolism as a Modulator of Kratom's Biological Actions
Type: Journal Article
Authors: S. Chakraborty, R. Uprety, S. T. Slocum, T. Irie, V. Le Rouzic, X. Li, L. L. Wilson, B. Scouller, A. F. Alder, A. C. Kruegel, M. Ansonoff, A. Varadi, S. O. Eans, A. Hunkele, A. Allaoa, S. Kalra, J. Xu, Y. X. Pan, J. Pintar, B. M. Kivell, G. W. Pasternak, M. D. Cameron, J. P. McLaughlin, D. Sames, S. Majumdar
Year: 2021
Abstract:

The leaves of Mitragyna speciosa (kratom), a plant native to Southeast Asia, are increasingly used as a pain reliever and for attenuation of opioid withdrawal symptoms. Using the tools of natural products chemistry, chemical synthesis, and pharmacology, we provide a detailed in vitro and in vivo pharmacological characterization of the alkaloids in kratom. We report that metabolism of kratom's major alkaloid, mitragynine, in mice leads to formation of (a) a potent mu opioid receptor agonist antinociceptive agent, 7-hydroxymitragynine, through a CYP3A-mediated pathway, which exhibits reinforcing properties, inhibition of gastrointestinal (GI) transit and reduced hyperlocomotion, (b) a multifunctional mu agonist/delta-kappa antagonist, mitragynine pseudoindoxyl, through a CYP3A-mediated skeletal rearrangement, displaying reduced hyperlocomotion, inhibition of GI transit and reinforcing properties, and (c) a potentially toxic metabolite, 3-dehydromitragynine, through a non-CYP oxidation pathway. Our results indicate that the oxidative metabolism of the mitragynine template beyond 7-hydroxymitragynine may have implications in its overall pharmacology in vivo.

Topic(s):
Opioids & Substance Use See topic collection
7075
Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial
Type: Journal Article
Authors: Christopher S. Stauffer, Jenna M. Moschetto, Scott McKernan, Nathan Meinzer, Chavy Chiang, Rachel Rapier, Elaine Hsiang, Jerika Norona, Brian Borsari, Joshua D. Woolley
Year: 2020
Publication Place: Elmsford
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7076
Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial
Type: Journal Article
Authors: C. S. Stauffer, J. M. Moschetto, S. M. McKernan, E. Hsiang, B. Borsari, J. D. Woolley
Year: 2019
Abstract:

BACKGROUND: The prevalence of methamphetamine use disorder (MUD) in the United States has risen dramatically in the past four decades and is concentrated in populations such as men who have sex with men (MSM). Despite the public health consequences of MUD, there are no FDA-approved psychopharmacological treatments. Psychosocial treatment alone has been shown to reduce methamphetamine use, but high attrition rates limit treatment efficacy. Promising findings from animal models of MUD using exogenous oxytocin, a social neuropeptide, have set the stage for translational work. Along with unique anti-addiction effects, oxytocin holds a primary role in enhancing social salience and modulating stress. In humans, oxytocin administration, combined with evidence-based psychosocial interventions, may act synergistically to improve addiction treatment outcomes and improve retention rates in current MUD treatment. METHODS/DESIGN: We are conducting a randomized, double-blind, placebo-controlled trial of oxytocin-enhanced motivational interviewing group therapy (MIGT). Oxytocin or placebo 40 IU is administered intranasally in conjunction with six, weekly MIGT sessions. We will recruit 50 MSM, initiating treatment for MUD from specialized community health programs in San Francisco, CA, USA. Individuals will be randomized (1:1) to receive six, weekly sessions of MIGT with or without oxytocin. Our primary outcome is session attendance. Other outcomes of interest include: measures of group cohesion, anxiety, psychophysiology, and stimulant craving and use. DISCUSSION: This will be the first study of oxytocin's effects in humans with MUD. Findings from this novel protocol will attempt to bridge existing animal data with the need for innovative clinical treatments for MUD, inform the growing field of pharmacologically-enhanced psychotherapy, and help to elucidate mechanisms behind oxytocin's potential anti-addiction effects. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02881177 . Registered on 26 August 2016.

Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7077
Paediatric integrated care in the primary care setting: A scoping review of populations served, models used and outcomes measured
Type: Journal Article
Authors: Jill D. McLeigh, Lauren Malthaner, Caitlin Winebrenner, Kimberly E. Stone
Year: 2022
Topic(s):
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
7078
Pain in methadone patients: Time to address undertreatment and suicide risk (ANRS-Methaville trial)
Type: Journal Article
Authors: S. Nordmann, A. Vilotitch, C. Lions, L. Michel, M. Mora, B. Spire, G. Maradan, M. K. Bendiane, A. Morel, P. Roux, P. Carrieri, ANRS Methaville Study Group
Year: 2017
Publication Place: United States
Abstract: BACKGROUND: Pain in opioid-dependent patients is common but data measuring the course of pain (and its correlates) using validated scales in patients initiating methadone treatment are sparse. We aimed to assess pain and its interference in daily life, associated correlates, and undertreatment before and during methadone treatment. METHODS: This is a secondary analysis using longitudinal data of a randomized trial comparing two methadone initiation models. We assessed the effect of methadone initiation and other correlates on pain intensity and interference (using the Brief Pain Inventory) at months 0, 6 and 12 using a mixed multinomial logistic regression model. RESULTS: The study group comprised 168 patients who had data for either pain intensity or interference for at least one visit. Moderate to severe pain was reported in 12.9% of patients at M0, 5.4% at M6 and 7.3% at M12. Substantial interference with daily functioning was reported in 36.0% at M0, 14.5% at M6 and 17.1% at M12. Of the 98 visits where patients reported moderate to severe pain or substantial interference, 55.1% reported no treatment for pain relief, non-opioid analgesics were reported by 34.7%, opioid analgesics by 3.1% and both opioid and non-opioid analgesics by 7.1%. Methadone was associated with decreased pain intensity at 6 months (OR = 0.29, p = 0.04) and 12 months (OR = 0.30, p = 0.05) of follow-up and tended to be associated with substantial pain interference. Suicide risk was associated with both pain intensity and pain interference. CONCLUSIONS: Methadone in opioid-dependent patients can reduce pain. However, undertreatment of pain in methadone patients remains a major clinical concern. Patients with pain are at higher risk of suicide. Adequate screening and management of pain in this population is a priority and needs to be integrated into routine comprehensive care.
Topic(s):
Opioids & Substance Use See topic collection
7079
Pain in primary care patients with bipolar disorder
Type: Journal Article
Authors: J. M. Cerimele, Y. F. Chan, L. A. Chwastiak, J. Unutzer
Year: 2014
Publication Place: United States
Topic(s):
General Literature See topic collection
7080
Pain in the Nation 2023: The Epidemics of Alcohol, Drug, and Suicide Deaths
Type: Government Report
Authors: Molly Warren, Brandon Reavis
Year: 2023
Publication Place: Washington, D.C.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Policy See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.